To Gilead Clause Samples
The "To Gilead" clause designates specific rights, obligations, or benefits that are to be provided directly to Gilead under the agreement. In practice, this clause may outline deliverables, payments, or information that must be sent or made available to Gilead, such as reports, royalties, or notifications. Its core function is to ensure that Gilead receives what it is entitled to under the contract, thereby clarifying responsibilities and reducing the risk of misunderstandings between the parties.
To Gilead. Gilead shall maintain such records and the information disclosed therein in confidence in accordance with ARTICLE 7. [***] Confidential treatment requested pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. Omitted portions have been filed separately with the Commission.
To Gilead. Subject to the terms and conditions of this Agreement and any Ancillary Agreements, with respect to any Gilead Country and any ▇▇▇▇▇▇▇ Country with respect to which Gilead (or its Affiliate, Sublicensee or Third Party Distributor) is the MA Holder for a Territory Combination Product, ▇▇▇▇▇▇▇ (including on behalf of its Affiliates) hereby grants, and shall cause its (sub)licensees and Third Party distributors for the RPV Single Agent Product to grant, to Gilead (and its Affiliates, Sublicensees, or Third Party Distributors, as applicable), in ▇▇▇▇▇▇▇’▇ (or its Affiliate’s or (sub)licensee’s or Third Party Distributor’s, as applicable) capacity as the MA Holder of the RPV Single Agent Product, in the Field in such country, a non-exclusive Right of Reference, with the right to grant further Rights of Reference to the extent permitted pursuant to Section 9.3, with regard to the ▇▇▇▇▇▇▇ Regulatory Documentation for the RPV Single Agent Product in the Field in such country, as necessary or reasonably expected to be necessary to, and for the sole purpose of allowing Gilead (or its Affiliates, Third Party Distributors or Sublicensees, as applicable) to, obtain and maintain Regulatory Approvals for such Territory Combination Product in the Field in such country or to comply with Applicable Law. Within ten (10) Business Days following Gilead’s request, ▇▇▇▇▇▇▇ shall deliver to Gilead an executed Right of Reference letter with respect to any Right of Reference granted herein. For clarity, such Rights of Reference granted to Gilead under this Section 9.2.1 shall be to the entire item of ▇▇▇▇▇▇▇ Regulatory Documentation (not portions thereof) and shall include those listed as items 1 through 3 (in the case of Territory Complera) or 4 through 6 (in the case of the Territory R/F/TAF Product) in Annex II. ▇▇▇▇▇▇▇ agrees to provide any required signed statement to that effect in accordance with the applicable Regulatory Authority’s position on authorization to cross reference. Such Right of Reference granted under this Section 9.2.1 shall be paid-up, perpetual and non-exclusive upon the expiration of this Agreement with respect to the applicable country as provided in Section 19.1.
To Gilead. Tibotec hereby grants to Gilead a co-exclusive with Tibotec and its Affiliates, royalty-free license, with the right to grant sublicenses to the extent permitted pursuant to Section 9.3, under the Tibotec Technology and any and all rights, title and interest that Tibotec may have in and to any Joint Technology, solely to conduct Commercialization Activities with respect to the Combination Product (but not to Exploit the TMC278 API individually or in combination other than in the Combination Product) in the Field in the Territory pursuant to and in accordance with the terms of this Agreement and any Ancillary Agreements.
To Gilead. Subject to the terms and conditions of this Agreement, on a Program-by-Program basis, during the Research Collaboration Term for such Program, SR hereby grants to Gilead a non-exclusive, worldwide, fully paid-up, royalty-free right and license, with the right to grant sublicenses (subject to Section 6.2), under the SR IP solely for the purpose of Gilead conducting its activities for such Program in the Field under this Agreement or any applicable Material Transfer Agreement.